Seleziona la lingua

Get in touch with Sleepacta:

clienti-header@2x

Customers and Partners

Sleepacta Network
Home > About Us > Customers and Partners
Scientifically validated technologies, at the service of our customers

Sleepacta boasts partnerships and develops projects in collaboration with schools of excellence, research centers and university foundations of international standing, and applies its technologies in the field, in collaboration with hospitals.

List of Partners and Customers

The project was initiated in 2020, with the aim to analyze the impact on sleep of young patients, wearing alarmed continuous glucose monitoring (CGM) sensors used for continuous blood glucose monitoring in pediatric patients with Type I Diabetes (T1D). Forty-seven children/adolescents were monitored by actigraphy with Dormi algorithm, and the result of the study confirmed improved metabolic control of hypoglycemia in the use of CGM sensors, without negatively impacting the duration and quality of sleep, thus leading to an improvement in the quality of life, both for patients and for young parents and family members.
Paper: Franceschi, R., Scotton, C., Leonardi, L. et al. Impact of intermittently scanned continuous glucose monitoring with alarms on sleep and metabolic outcomes in children and adolescents with type 1 diabetes. Acta Diabetol 59, 911–919 (2022). https://doi.org/10.1007/s00592-022-01882-3

Read more Reduce

Stella Maris Foundation is the IRCCS Scientific Institute for the diagnosis and treatment of Childhood and Adolescent Neuropsychiatric Disorders. Neuropsychiatric disorders of childhood and adolescence are very heterogeneous and collectively affect with a frequency of about 1 every 5 children and are therefore among the most common childhood disorders. Often sleep disturbances in these children are a cause or a consequence of these disorders and being able to objectively monitor sleep by means of a minimally invasive sensor in this large population of children allows to identify specific features of individual profiles, supporting clinicians for proper therapeutic framing.

Read more Reduce

The PREMED2 project, aimed at the prevention, through precision medicine, of Type II Diabetes, was initiated with the Department of Medicine. Identifying subjects at high risk of developing type 2 diabetes can facilitate the development of preventive interventions to focus on those who will benefit, saving costs and potential side effects for subjects at lower risk. For this project, it is intended to recruit at least 1,200 subjects with ≥20% risk of developing diabetes over the next 10 years, and they will be grouped and typified on the basis of dietary habits, physical activity (using Sleepacta wearable device), and metabolic profile.

Read more Reduce

The Santagostino is a network of comprehensive specialist outpatient clinics known for the high quality and affordable rates of its services. Founded in 2009, the Santagostino was created to respond to a growing unmet need of a large part of the population: high-level, affordable specialist medicine that also covers areas uncovered by public healthcare. Sleepacta fits into the sleep disorders outpatient clinic, providing the patient with the possibility of remote and objective sleep monitoring over an extended period of days, thus providing the sleep expert with a completer and more accurate tool for patient assessment.

Read more Reduce

Medispa is a service company offering wellness medicine solutions through innovative, usable, simple and reliable diagnostic tools. It conveys its offerings through specific web-based platforms to many different channels such as wellness centers and Pharmacies. The i-care platform, identified as a "prevention suite," in fact, integrates solutions from third-party companies within it, thus making them available to further users. Sleepacta has integrated within Medispa's interactive i-care platform, the DORMI algorithm, thus allowing users of the Pharmacies themselves, to book and measure their sleep directly in the Pharmacy.

Read more Reduce

Dravet syndrome is a rare form of childhood epilepsy. The Dravet Italia is a non-profit organization (NGO), established through the cooperation of parents and doctors with the intent of improving the quality of life of children with this serious condition. The purpose of the association is to support clinical research aimed at a greater understanding of the disease itself with the objective of finding increasingly more effective therapies and treatment options. Sleepacta fits perfectly to the needs of this organization as it offers a noninvasive sleep monitoring tool for young patients suffering from Dravet syndrome.

Read more Reduce

In collaboration with the Italian Association of Sleep Physicians, a research project was initiated on patients with Alzheimer's disease and patients with Mild cognitive impairment (MCI) to evaluate the impact of sleep and circadian parameters as a cause or perhaps effect of the occurrence of this neurodegeneration. Indeed, some specific actigraphic features are appreciable in the early stage of the disease. Additionally, with Dormi it also becomes possible to monitor not only the sleep profile but also the daytime activity: this could result in a new method of analysis and monitoring of patients undergoing cognitive-behavioral treatment.

Read more Reduce

Whole Sleepacta network

Background-Hero

Profile

Innovating and simplifying sleep diagnostics

Sleepacta is a startup company spin-off of the University of Pisa, which was born from the experience of a team of researchers, doctors and engineers who have been studying sleep for years, from its role in the modulation of sports performance to its clinical impairment.

BG-Team

Team

A team of sleep scientists

Sleepacta counts, among its founders, a group of Italian researchers, engineers and clinicians, who still lead the company’s scientific team today. Most of them, who come from the academic excellence of the university Scuola Superiore e di Perfezionamento of the Sant’Anna in Pisa, gained added experience abroad at the world’s best research labs on sleep-wake cycle regulation mechanisms.

In addition to neuroscientific know-how, the team offers a very high level of expertise in Artificial Intelligence tools and techniques. The skills of the founding team have been harmonized and integrated with professional profiles coming from corporate backgrounds with experience in multinational contexts. This has given Sleepacta a new and more efficient structure in the process of development and conversion from a University spin-off to full-fledged company.